Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.53 |
| ▸ | FAAH | O00519 | 8/20 | 0.52 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.45 |
| ▸ | ELANE | P08246 | 2/20 | 0.42 |
| ▸ | RPS6KA2 | Q15349 | 1/20 | 0.36 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.36 |
| ▸ | SSTR5 | P35346 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16380661 | 0.77 | FAAH (0.63) | HDAC6FAAHPIK3CAELANE | |
| SCHEMBL29970034 | 0.77 | HDAC6 (0.53) | HDAC6FAAHPIK3CAELANECXCR3 | |
| SCHEMBL28611218 | 0.77 | HDAC6 (0.53) | HDAC6FAAHPIK3CAELANECXCR3 | |
| SCHEMBL13436761 | 0.75 | HDAC6 (0.62) | HDAC6FAAHPIK3CAELANESSTR5 | |
| SCHEMBL13370383 | 0.75 | POLB (0.35) | PIK3CA | |
| SCHEMBL7899481 | 0.75 | PIK3CA (0.45) | HDAC6PIK3CA | |
| SCHEMBL3478062 | 0.75 | NPC1 (0.54) | HDAC6FAAH | |
| SCHEMBL28479671 | 0.75 | CA1 (0.43) | — | |
| SCHEMBL14494690 | 0.74 | HDAC6 (0.58) | HDAC6FAAHPIK3CAELANESSTR5 | |
| SCHEMBL18613753 | 0.74 | HDAC6 (0.38) | HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010039186-A2 | COMPOUNDS USEFUL AS FAAH MODULATORS AND USES THEREOF | RENOVIS, INC. (US) | 2010-04-08 | — | — | WO | disclosed |
| WO-2010039186-A2 | COMPOUNDS USEFUL AS FAAH MODULATORS AND USES THEREOF | RENOVIS, INC. (US) | 2010-04-08 | — | — | WO | disclosed |